The LJ Hooker Foundation – the charity arm of LJ Hooker offices nationwide – will donate the full purchase price of the three-bedroom, two-bathroom home at Malua Bay, New South Wales, to Cystic Fibrosis Australia (CFA), to continue its advocacy and support for those living with the condition.
The home has been named Red Rose House in honour of CFA’s emblem.
The idea is the brainchild of former LJ Hooker agent Michael Skuse. More than two hundred volunteers, including representatives of multinationals and SMEs, were involved in the project.
LJ Hooker CEO Grant Harrod said it was fitting that the product of community goodwill would go to such an important cause.
“To have the house come out of the ground, from the sourcing of land to the bespoke finishes and final internal fittings, is an enormous achievement,” Mr Harrod said.
“We’re very pleased for the LJ Hooker offices and wider business leaders whose generosity will be acknowledged and turned over to the CF [cystic fibrosis] community on January 28.”
Mr Harrod said Red Rose House was a “touching example” of community goodwill, adding that the LJ Hooker Foundation was proud to be supporting the project.
“And for the successful bidders, they’ll likewise be credited with making a significant contribution to the CF community, which itself is very exciting.”
Cystic Fibrosis Australia CEO Nettie Burke thanked the LJ Hooker Foundation for the donation, saying the house was a poignant representation of life with cystic fibrosis.
“Building a home is a step-by-step process. Likewise, living with cystic fibrosis involves regimented, step-by-step living that involves a tortuous combination of hours of physiotherapy and countless daily intakes of life saving drugs,” Ms Burke said.
Situated in a holiday spot popular with Sydneysiders and Canberrans, the Red Rose house is located only 15 minutes from Batemans Bay, NSW and approximately two hours from Canberra.
All money raised from the sale of Red Rose House will go to Cystic Fibrosis Australia’s research programs and support its efforts to increase life expectancy from 37 to 50 years by 2025.